IL-10 Receptor: A Protein Involved in A Variety of Physiological Processes
IL-10 Receptor: A Protein Involved in A Variety of Physiological Processes
The IL-10 receptor, also known as IL-10R, is a protein that is expressed in a variety of tissues throughout the body, including the immune system, gastrointestinal tract, and nervous system. It is a member of the IL-1 family of cytokines, which are a group of signaling proteins that play a critical role in the immune response and inflammation.
The IL-10 receptor is involved in the regulation of a wide range of physiological processes in the body, including immune cell function, inflammation, and tissue repair. It is one of the key targets for drugs that are used to treat a variety of conditions, including autoimmune diseases, cancer, and respiratory infections.
The IL-10 receptor is composed of a extracellular domain that is responsible for the receptor's interaction with its ligand, as well as an intracellular domain that is involved in the signaling pathway that is initiated by the ligand. The intracellular domain includes a number of transmembrane signaling channels, as well as a protein that is involved in the interaction with the cytoskeleton.
The IL-10 receptor is involved in the regulation of a wide range of physiological processes in the body, including immune cell function, inflammation, and tissue repair.
One of the key functions of the IL-10 receptor is its role in the regulation of immune cell function. The receptor is involved in the development and activation of T cells, which are a critical component of the immune system. It is also involved in the regulation of B cells, which are responsible for producing antibodies as part of the immune response.
In addition to its role in immune cell function, the IL-10 receptor is also involved in the regulation of inflammation. The receptor is involved in the production of pro-inflammatory cytokines, as well as the regulation of the activity of immune cells that are involved in inflammation.
The IL-10 receptor is also involved in the regulation of tissue repair. After injury or damage to tissues, the receptor helps to promote the recruitment of immune cells to the site of injury and facilitate the process of tissue repair.
The IL-10 receptor is a potential drug target for a variety of conditions, including autoimmune diseases, cancer, and respiratory infections. Many drugs that are used to treat these conditions work by modulating the activity of the IL-10 receptor. For example, drugs that are used to treat autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, work by inhibiting the activity of the IL-10 receptor.
In addition to its potential as a drug target, the IL-10 receptor is also a potential biomarker for a variety of conditions. The receptor is often expressed in tissues that are affected by the condition being studied, which makes it a useful indicator of the presence of the condition. For example, the IL-10 receptor is often expressed in tissues that are affected by cancer, and so it may be used as a biomarker for cancer diagnosis and treatment.
Overall, the IL-10 receptor is a complex protein that is involved in a wide range of physiological processes in the body. It is a potential drug target for a variety of conditions, including autoimmune diseases, cancer, and respiratory infections. Further research is needed to fully understand the role of the IL-10 receptor in these processes, as well as its potential as a biomarker.
Protein Name: IL-10 Receptor
The "IL-10 Receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL-10 Receptor comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
IL-11 receptor | IL-12 receptor | IL-13 receptor | IL-15 receptor | IL-17 Receptor | IL-2 receptor | IL-20 receptor | IL-22 Receptor | IL-23 receptor complex | IL-27 receptor | IL-3 receptor | IL-31 Receptor | IL-4 receptor | IL-5 receptor | IL-6 receptor | IL10 | IL10RA | IL10RB | IL10RB-DT | IL11 | IL11RA | IL12A | IL12A-AS1 | IL12B | IL12RB1 | IL12RB2 | IL13 | IL13RA1 | IL13RA2 | IL15 | IL15RA | IL16 | IL17A | IL17B | IL17C | IL17D | IL17F | IL17RA | IL17RB | IL17RC | IL17RD | IL17RE | IL17REL | IL18 | IL18BP | IL18R1 | IL18RAP | IL19 | IL1A | IL1B | IL1F10 | IL1R1 | IL1R2 | IL1RAP | IL1RAPL1 | IL1RAPL2 | IL1RL1 | IL1RL2 | IL1RN | IL2 | IL20 | IL20RA | IL20RB | IL21 | IL21-AS1 | IL21R | IL21R-AS1 | IL22 | IL22RA1 | IL22RA2 | IL23A | IL23R | IL24 | IL25 | IL26 | IL27 | IL27RA | IL2RA | IL2RB | IL2RG | IL3 | IL31 | IL31RA | IL32 | IL33 | IL34 | IL36A | IL36B | IL36G | IL36RN | IL37 | IL3RA | IL4 | IL4I1 | IL4R | IL5 | IL5RA | IL6 | IL6-AS1 | IL6R
